Status:
COMPLETED
Effects of ABO Blood Types on the Survival and Marginal Bone Resorption of Dental Implants
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Implant Tissue Failure
Eligibility:
All Genders
19-78 years
Brief Summary
This study evaluates implant survival and marginal bone resorption in patients receiving implant treatment with respect to demographic data and AB0 (groups) blood types.
Detailed Description
For a successful dental implant, optimal soft and hard tissue characteristics are required. These characteristics include appropriate bone quality and a healthy adherent keratinized gingiva that surro...
Eligibility Criteria
Inclusion
- The inclusion criteria for the study group included being 18 years of age and non-smoker, not having any systemic disease, not having undergone any hard and soft tissue augmentation during implant surgery, having implants placed at bone level, having received cylindrical form implants with SLA surface structure, not missing any follow-up visits after implant surgery evidenced with radiographic recordings, having received flat abutment, having cemented implants, and being rehabilitated with fixed prosthetic restoration.
Exclusion
- No
Key Trial Info
Start Date :
December 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2018
Estimated Enrollment :
963 Patients enrolled
Trial Details
Trial ID
NCT04054271
Start Date
December 15 2017
End Date
December 15 2018
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Serap Keskin Tunc
Van, Turkey (Türkiye), 65100